PharmaShots | Incisive News in 3 Shots

Subscribe Now

Intercept Pharmaceutical

Intercept Pharmaceutical Reports the results for OCA + Bezafibrate in P-II trial to treat PBC-Induced Liver Damage

Intercept Pharmaceutical Reports the results for OCA + Bezafibrate in P-II trial to treat PBC-Induced Liver Damage

November 14, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us